Eptifibatide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Eptifibatide — research data
Regulatory statusFDA-approved (Integrilin)
NCAA D1Not listed
Overview
About Eptifibatide
Mechanism of action
GP IIb/IIIa receptor inhibitor; prevents platelet aggregation via fibrinogen receptor blockade
Safety profile
Bleeding complications, thrombocytopenia, hypotension · Extensive use in cardiology; bleeding risk expected; thrombocytopenia rare
Related pages